What really bothers oncology patients

Editorial

I J Cohen. Pediatr Hematol Oncol. 2000 Sep.

. 2000 Sep;17(6):439-40.

doi: 10.1080/08880010050120773.

No abstract available

Comment in

A comparison of oral ondansetron syrup or intravenous ondansetron loading dose regimens given in combination with dexamethasone for the prevention of nausea and emesis in pediatric and adolescent patients receiving moderately/highly emetogenic chemotherapy.
White L, Daly SA, McKenna CJ, Zhestkova N, Leal C, Breatnach F, Smelhaus V, Hung IJ, Kowalczyk J, Ninane J, Mitchell T, Haigh C. White L, et al. Pediatr Hematol Oncol. 2000 Sep;17(6):445-55. doi: 10.1080/08880010050120791. Pediatr Hematol Oncol. 2000. PMID: 10989464 Clinical Trial.

[Hospital network in pediatric oncology].
Doz F. Doz F. Arch Pediatr. 2006 Jun;13(6):635-7. doi: 10.1016/j.arcped.2006.03.091. Epub 2006 May 12. Arch Pediatr. 2006. PMID: 16697587 French. No abstract available.
[The child and cancerous diseases (current general aspects of pediatric oncology)].
Goldiş G. Goldiş G. Rev Pediatr Obstet Ginecol Pediatr. 1982 Jan-Mar;31(1):3-14. Rev Pediatr Obstet Ginecol Pediatr. 1982. PMID: 6808641 Review. Romanian. No abstract available.
Interferon-alpha therapy in children with malignant diseases: clinical experience in twenty-four patients treated in a single pediatric oncology unit.
Kiss C, Kiss M, Szegedi I, Arvai K, Tóth J, Oláh E. Kiss C, et al. Med Pediatr Oncol. 2002 Aug;39(2):115-9. doi: 10.1002/mpo.10088. Med Pediatr Oncol. 2002. PMID: 12116059 No abstract available.
[Progress in chemotherapy. Secondary effects].
Bezanilla Regato JL. Bezanilla Regato JL. An Esp Pediatr. 1988 Sep;29 Suppl 32:93-5. An Esp Pediatr. 1988. PMID: 3247978 Spanish. No abstract available.
[Dermatologic manifestations of infections in pediatric cancer patients].
Ott H, Höger PH. Ott H, et al. Klin Padiatr. 2005 Nov;217 Suppl 1:S110-9. doi: 10.1055/s-2005-872505. Klin Padiatr. 2005. PMID: 16288357 Review. German.